A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

You may be eligible if

• Relapsed or Refractory Multiple Myeloma
• ≥ 18 years old
• Able to provide consent for participation
• ECOG status 0-2
• Lab values:
• ANC ≥ 1,000/µL
• WBC count ≥ 2.0/µL
• Hemoglobin ≥ 8.0 g/dL
• Platelet count ≥ 50,000/µL
• AST and ALT ≤ 2 x ULN
• Total Bilirubin ≤ 2 x ULN
• Creatinine ≤ 2.0 mg/dL
• and
• Not pregnant or lactating